La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Ameritrust a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Ameritrust..

Ameritrust (OTC:ATCC) Azioni, Catena delle Opzioni

Ameritrust Corp is a financial company providing various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, China, and Asia. The Investment Banking and Institutional Securities Segment offers capital raising and financial advisory services, including services related to the underwriting of IPO, Equity, Debt, Private Placements and Other Securities, as well as advice on Mergers and Acquisitions, Restructurings, Real Estate, REIT, Limited Partnerships, and project finance. The Wealth Management Segment offers various financial services and solutions. The Investment Management Segment provides various investment strategies and products.

AMERITRUST CORPORATION by Ameritrust Corporation

Ameritrust Corp

<p>Goldman Sachs  analyst Jamie Perse   maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Neutral and raises the price target from $134 to $154.</p>


News

Price Target

Analyst Ratings

Goldman Sachs Maintains Neutral on Tenet Healthcare, Raises Price Target to $154

<p>Goldman Sachs  analyst Andrea Tan   maintains Tarsus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) with a Neutral and raises the price target from $46 to $51.</p>


TARS

Goldman Sachs Maintains Neutral on Tarsus Pharmaceuticals, Raises Price Target to $51

<p><a href="https://www.youtube.com/live/qhAQ_sImdOM">https://www.youtube.com/live/qhAQ_sImdOM</a></p>
<p>&nbsp;</p>


Macro Economic Events

Politics

Global

Economics

General

Watching S&P Futures; At Milken Conference, U.S. Treasury Secretary Bessent Says Trump Tax Legislation To Restore 100% Expensing For Equipment, Expand Full Expensing To Factory Construction, Provide Tax Credits, Deductions For Research And Innovation; U.S. Markets Are 'Antifragile,' Over A Long-Term Horizon It's Never A Bad Time To Invest In America

<p><a href="https://www.youtube.com/live/qhAQ_sImdOM" title="https://www.youtube.com/live/qhAQ_sImdOM">https://www.youtube.com/live/qhAQ_sImdOM</a></p>


Watching S&P Futures; At Milken Conference, U.S. Treasury Secretary Bessent Says Trump's Tariffs, Tax Cuts And Deregulation Agendas Are Interlocking Parts To Drive Long-Term Investment To U.S. Economy; Trump's Tax Legislation Will Prevent Main Street Tax Hike By Making Small Business Deduction Permanent

<p>Goldman Sachs  analyst John Mackay   maintains Targa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) with a Buy and lowers the price target from $218 to $194.</p>


TRGP

Goldman Sachs Maintains Buy on Targa Resources, Lowers Price Target to $194

WIIM

Shares of energy stocks are trading lower amid a drop in the price of oil. Oil fell on reports suggesting OPEC+ agreed to production increases in June.

<p>Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Celsius Holdings to report an <strong>earnings per share</strong> (EPS) of $0.21.</p>
<p>The announcement from Celsius Holdings is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.04, leading to a 27.77% increase in the share price the following trading session.</p>
<p>Here's a look at Celsius Holdings's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.10</td>
<td>0.03</td>
<td>0.24</td>
<td>0.19</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.14</td>
<td>0</td>
<td>0.28</td>
<td>0.27</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>28.000000000000004%</td>
<td>-0.0%</td>
<td>-2.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457389_0.png" alt="eps graph" /></p>
<h3>Market Performance of Celsius Holdings's Stock</h3>
<p>Shares of Celsius Holdings were trading at $34.46 as of May 02. Over the last 52-week period, shares are down 55.58%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<h3>Insights Shared by Analysts on Celsius Holdings</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Celsius Holdings.</p>
<p>Analysts have provided Celsius Holdings with 9 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $44.78, suggesting a potential 29.95% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Primo Brands and National Beverage, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Primo Brands, with an average 1-year price target of $42.75, suggesting a potential 24.06% upside.</li>
<li>Analysts currently favor an Sell trajectory for National Beverage, with an average 1-year price target of $41.0, suggesting a potential 18.98% upside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Primo Brands and National Beverage, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Celsius Holdings</td>
<td>Buy</td>
<td>-4.39%</td>
<td>$166.67M</td>
<td>-5.72%</td>
</tr>
<tr>
<td>Primo Brands</td>
<td>Buy</td>
<td>28.66%</td>
<td>$430.10M</td>
<td>-9.85%</td>
</tr>
<tr>
<td>National Beverage</td>
<td>Sell</td>
<td>-1.12%</td>
<td>$98.95M</td>
<td>10.43%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Celsius Holdings ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is also at the bottom for Return on Equity.</p>
<h3>All You Need to Know About Celsius Holdings</h3>
<p>Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), Celsius On-the-Go powder packets, and soon-to-be-acquired Alani Nu energy drinks and snacks portfolio. Celsius dedicates its efforts to branding and innovation, while it largely utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.</p>
<h3>Key Indicators: Celsius Holdings's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Challenges:</strong> Celsius Holdings's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately <strong>-4.39%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.</p>
<p><strong>Net Margin:</strong> Celsius Holdings's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-7.09%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-5.72%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Celsius Holdings's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-1.36%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Celsius Holdings's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.05</strong>.</p>
<p><a href="https://www.benzinga.com/quote/CELH/earnings"><strong>To track all earnings releases for Celsius Holdings visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

CELH

What's Next: Celsius Holdings's Earnings Preview

<p><strong>UWM Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UWMC#NYSE">UWMC</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-05-06. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that UWM Hldgs will report an <strong>earnings per share</strong> (EPS) of $0.05. </p>
<p>Anticipation surrounds UWM Hldgs's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company missed EPS by $0.06, which was followed by a 1.94% drop in the share price the next day.</p>
<p>Here's a look at UWM Hldgs's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.08</td>
<td>0.08</td>
<td>0.07</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.02</td>
<td>0.01</td>
<td>0.04</td>
<td>0.09</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>1.0%</td>
<td>-4.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457376_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of UWM Hldgs were trading at $4.88 as of May 02. Over the last 52-week period, shares are down 31.77%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/UWMC/earnings"><strong>To track all earnings releases for UWM Hldgs visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


UWMC

Earnings Outlook For UWM Hldgs

<p>Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Halozyme Therapeutics to report an <strong>earnings per share</strong> (EPS) of $0.96.</p>
<p>The announcement from Halozyme Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company beat EPS by $0.10, which was followed by a 0.22% drop in the share price the next day.</p>
<p>Here's a look at Halozyme Therapeutics's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.16</td>
<td>0.98</td>
<td>0.78</td>
<td>0.69</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.26</td>
<td>1.27</td>
<td>0.91</td>
<td>0.79</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>13.0%</td>
<td>4.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457366_0.png" alt="eps graph" /></p>
<h3>Tracking Halozyme Therapeutics's Stock Performance</h3>
<p>Shares of Halozyme Therapeutics were trading at $61.19 as of May 02. Over the last 52-week period, shares are up 47.71%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Views on Halozyme Therapeutics</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Halozyme Therapeutics.</p>
<p>Analysts have provided Halozyme Therapeutics with 5 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $69.4, suggesting a potential 13.42% upside.</p>
<h3>Peer Ratings Overview</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Roivant Sciences and Exact Sciences, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Roivant Sciences, with an average 1-year price target of $18.0, suggesting a potential 70.58% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Exact Sciences, with an average 1-year price target of $63.92, suggesting a potential 4.46% upside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Roivant Sciences and Exact Sciences, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Halozyme Therapeutics</td>
<td>Buy</td>
<td>29.55%</td>
<td>$255.95M</td>
<td>33.56%</td>
</tr>
<tr>
<td>Roivant Sciences</td>
<td>Buy</td>
<td>-42.05%</td>
<td>$8.76M</td>
<td>3.28%</td>
</tr>
<tr>
<td>Exact Sciences</td>
<td>Outperform</td>
<td>10.86%</td>
<td>$500.55M</td>
<td>-4.22%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Halozyme Therapeutics ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has a lower Return on Equity compared to its peers.</p>
<h3>Discovering Halozyme Therapeutics: A Closer Look</h3>
<p>Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.</p>
<h3>Halozyme Therapeutics: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Halozyme Therapeutics's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>29.55%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Halozyme Therapeutics's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>45.98%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Halozyme Therapeutics's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>33.56%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Halozyme Therapeutics's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>6.55%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>4.14</strong>, Halozyme Therapeutics faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/HALO/earnings"><strong>To track all earnings releases for Halozyme Therapeutics visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


HALO

Insights into Halozyme Therapeutics's Upcoming Earnings

<p>Goldman Sachs  analyst Kate McShane   maintains RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) with a Neutral and lowers the price target from $276 to $194.</p>


Goldman Sachs Maintains Neutral on RH, Lowers Price Target to $194

<p>Peabody Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Peabody Energy to report an <strong>earnings per share</strong> (EPS) of $0.10.</p>
<p>Anticipation surrounds Peabody Energy's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $0.12, leading to a 2.57% drop in the share price the following trading session.</p>
<p>Here's a look at Peabody Energy's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.37</td>
<td>0.58</td>
<td>0.61</td>
<td>0.31</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.25</td>
<td>0.74</td>
<td>1.42</td>
<td>0.29</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>1.0%</td>
<td>-3.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457356_0.png" alt="eps graph" /></p>
<h3>Peabody Energy Share Price Analysis</h3>
<p>Shares of Peabody Energy were trading at $12.81 as of May 02. Over the last 52-week period, shares are down 38.87%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Analysts' Perspectives on Peabody Energy</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Peabody Energy.</p>
<p>With 2 analyst ratings, Peabody Energy has a consensus rating of Buy. The average one-year price target is $22.5, indicating a potential 75.64% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Centrus Energy, Hallador Energy and Alliance Res Partners, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Centrus Energy, with an average 1-year price target of $177.67, suggesting a potential 1286.96% upside.</li>
<li>Analysts currently favor an Buy trajectory for Hallador Energy, with an average 1-year price target of $15.0, suggesting a potential 17.1% upside.</li>
<li>Analysts currently favor an Buy trajectory for Alliance Res Partners, with an average 1-year price target of $29.0, suggesting a potential 126.39% upside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Centrus Energy, Hallador Energy and Alliance Res Partners, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peabody Energy</td>
<td>Buy</td>
<td>-9.06%</td>
<td>$166.10M</td>
<td>0.84%</td>
</tr>
<tr>
<td>Centrus Energy</td>
<td>Buy</td>
<td>46.33%</td>
<td>$61.80M</td>
<td>45.16%</td>
</tr>
<tr>
<td>Hallador Energy</td>
<td>Buy</td>
<td>-21.21%</td>
<td>$61.71M</td>
<td>-102.01%</td>
</tr>
<tr>
<td>Alliance Res Partners</td>
<td>Buy</td>
<td>-8.41%</td>
<td>$64.13M</td>
<td>4.06%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Peabody Energy ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, Peabody Energy is at the bottom compared to its peers.</p>
<h3>About Peabody Energy</h3>
<p>Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan and other regions.</p>
<h3>A Deep Dive into Peabody Energy's Financials</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Challenges:</strong> Peabody Energy's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately <strong>-9.06%</strong>. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>2.72%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>0.84%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Peabody Energy's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.52%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Peabody Energy's debt-to-equity ratio is below the industry average. With a ratio of <b>0.13</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/BTU/earnings"><strong>To track all earnings releases for Peabody Energy visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview For Peabody Energy

<p><strong>Genius Sports</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-05-06. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Genius Sports will report an <strong>earnings per share</strong> (EPS) of $-0.02. </p>
<p>Anticipation surrounds Genius Sports's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings Track Record</h3>
<p>The company's EPS missed by $0.14 in the last quarter, leading to a 4.4% increase in the share price on the following day.</p>
<p>Here's a look at Genius Sports's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.02</td>
<td>-0.01</td>
<td>-0.03</td>
<td>-0.09</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.12</td>
<td>0.05</td>
<td>-0.09</td>
<td>-0.11</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>4.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457348_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Genius Sports were trading at $11.05 as of May 02. Over the last 52-week period, shares are up 107.38%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Opinions on Genius Sports</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Genius Sports.</p>
<p>Analysts have given Genius Sports a total of 8 ratings, with the consensus rating being Buy. The average one-year price target is $12.06, indicating a potential 9.14% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of PENN Entertainment, Intl Game Tech and Monarch Casino &amp; Resort, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for PENN Entertainment, with an average 1-year price target of $22.17, suggesting a potential 100.63% upside.</li>
<li>Analysts currently favor an Buy trajectory for Intl Game Tech, with an average 1-year price target of $20.0, suggesting a potential 81.0% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Monarch Casino &amp; Resort, with an average 1-year price target of $89.0, suggesting a potential 705.43% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>Within the peer analysis summary, vital metrics for PENN Entertainment, Intl Game Tech and Monarch Casino &amp; Resort are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Genius Sports</td>
<td>Buy</td>
<td>38.03%</td>
<td>$47.45M</td>
<td>-5.00%</td>
</tr>
<tr>
<td>PENN Entertainment</td>
<td>Neutral</td>
<td>19.61%</td>
<td>$546.40M</td>
<td>-4.50%</td>
</tr>
<tr>
<td>Intl Game Tech</td>
<td>Buy</td>
<td>-4.12%</td>
<td>$286M</td>
<td>13.91%</td>
</tr>
<tr>
<td>Monarch Casino &amp; Resort</td>
<td>Neutral</td>
<td>-6.78%</td>
<td>$72.84M</td>
<td>3.77%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Genius Sports ranks highest in Revenue Growth among its peers. It has the lowest Gross Profit margin. The company has the lowest Return on Equity compared to its peers.</p>
<h3>Discovering Genius Sports: A Closer Look</h3>
<p>Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.</p>
<h3>Genius Sports: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Genius Sports displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>38.03%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Genius Sports's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>-16.07%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Genius Sports's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-5.0%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Genius Sports's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-3.72%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> Genius Sports's debt-to-equity ratio is below the industry average at <strong>0.01</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/GENI/earnings"><strong>To track all earnings releases for Genius Sports visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


GENI

Earnings Preview: Genius Sports

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Broadcom</strong>.</p>
<p>Looking at options history for Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) we detected 36 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 61% of the investors opened trades with bullish expectations and 36% with bearish.</p>
<p>From the overall spotted trades, 5 are puts, for a total amount of $186,163 and 31, calls, for a total amount of $2,542,971.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $110.0 and $320.0 for Broadcom, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Broadcom options trades today is 2080.28 with a total volume of 9,679.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Broadcom's big money trades within a strike price range of $110.0 to $320.0 over the last 30 days.</p>
<h3>Broadcom Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457342_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$3.75</td>
<td>$3.65</td>
<td>$3.8</td>
<td>$320.00</td>
<td>$266.0K</td>
<td align="right">911</td>
<td align="right">831</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$37.7</td>
<td>$37.1</td>
<td>$37.7</td>
<td>$220.00</td>
<td>$188.5K</td>
<td align="right">174</td>
<td align="right">100</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$37.7</td>
<td>$37.1</td>
<td>$37.7</td>
<td>$220.00</td>
<td>$188.5K</td>
<td align="right">174</td>
<td align="right">50</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$16.85</td>
<td>$16.7</td>
<td>$16.75</td>
<td>$240.00</td>
<td>$167.5K</td>
<td align="right">919</td>
<td align="right">104</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/06/25</td>
<td>$16.85</td>
<td>$16.5</td>
<td>$16.85</td>
<td>$195.00</td>
<td>$166.8K</td>
<td align="right">653</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
</p>
<h3>About Broadcom</h3>
<p>Broadcom is the sixth-largest semiconductor company globally and has expanded into various software businesses, with over $30 billion in annual revenue. It sells 17 core semiconductor product lines across wireless, networking, broadband, storage, and industrial markets. It is primarily a fabless designer but holds some manufacturing in-house, like for its best-of-breed FBAR filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments.Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as Brocade, CA Technologies, and Symantec in software.</p>
<p>After a thorough review of the options trading surrounding Broadcom, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Broadcom's Current Market Status</h3>
<ul>
<li>With a volume of 3,019,391, the price of AVGO is down -0.72% at $202.18. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 31 days.</li>
</ul>
<h3>Expert Opinions on Broadcom</h3>
<p>4 market experts have recently issued ratings for this stock, with a consensus target price of $223.75.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Seaport Global has revised its rating downward to Buy, adjusting the price target to $230.<br />
&#x2A; An analyst from Citigroup persists with their Buy rating on Broadcom, maintaining a target price of $210.<br />
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Broadcom with a target price of $240.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Broadcom, targeting a price of $215. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Broadcom with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

AVGO

Looking At Broadcom's Recent Unusual Options Activity

<p>Mercury Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-06. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Mercury Sys will report an <strong>earnings per share</strong> (EPS) of $0.07.</p>
<p>Anticipation surrounds Mercury Sys's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS beat by $0.11 in the last quarter, leading to a 18.51% increase in the share price on the following day.</p>
<p>Here's a look at Mercury Sys's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.04</td>
<td>-0.08</td>
<td>0.02</td>
<td>-0.03</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.07</td>
<td>0.04</td>
<td>0.23</td>
<td>-0.26</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>19.0%</td>
<td>23.0%</td>
<td>18.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457339_0.png" alt="eps graph" /></p>
<h3>Performance of Mercury Sys Shares</h3>
<p>Shares of Mercury Sys were trading at $51.46 as of May 02. Over the last 52-week period, shares are up 76.61%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Observations about Mercury Sys</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Mercury Sys.</p>
<p>Analysts have provided Mercury Sys with 2 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $57.0, suggesting a potential 10.77% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Hexcel, AAR and V2X, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Hexcel, with an average 1-year price target of $61.27, suggesting a potential 19.06% upside.</li>
<li>Analysts currently favor an Buy trajectory for AAR, with an average 1-year price target of $79.0, suggesting a potential 53.52% upside.</li>
<li>Analysts currently favor an Outperform trajectory for V2X, with an average 1-year price target of $62.25, suggesting a potential 20.97% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Hexcel, AAR and V2X, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mercury Sys</td>
<td>Buy</td>
<td>13.00%</td>
<td>$60.83M</td>
<td>-1.20%</td>
</tr>
<tr>
<td>Hexcel</td>
<td>Neutral</td>
<td>-3.35%</td>
<td>$102.40M</td>
<td>1.89%</td>
</tr>
<tr>
<td>AAR</td>
<td>Buy</td>
<td>19.55%</td>
<td>$131.70M</td>
<td>-0.75%</td>
</tr>
<tr>
<td>V2X</td>
<td>Outperform</td>
<td>11.29%</td>
<td>$107.42M</td>
<td>2.47%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Mercury Sys ranks at the top for Revenue Growth among its peers. It is at the bottom for Gross Profit and Return on Equity.</p>
<h3>Delving into Mercury Sys's Background</h3>
<p>Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.</p>
<h3>Unraveling the Financial Story of Mercury Sys</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Mercury Sys showcased positive performance, achieving a revenue growth rate of <strong>13.0%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Mercury Sys's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-7.88%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Mercury Sys's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-1.2%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Mercury Sys's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-0.74%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Mercury Sys's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.44</strong>.</p>
<p><a href="https://www.benzinga.com/quote/MRCY/earnings"><strong>To track all earnings releases for Mercury Sys visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MRCY

Examining the Future: Mercury Sys's Earnings Outlook

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>ARM Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ARM, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 28 uncommon options trades for ARM Holdings.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 32% bullish and 67%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $549,230, and 21 are calls, for a total amount of $12,788,070.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $115.0 to $200.0 for ARM Holdings over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for ARM Holdings options trades today is 2057.64 with a total volume of 17,652.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for ARM Holdings's big money trades within a strike price range of $115.0 to $200.0 over the last 30 days.</p>
<h3>ARM Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457336_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ARM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/17/27</td>
<td>$46.1</td>
<td>$43.45</td>
<td>$45.7</td>
<td>$125.00</td>
<td>$9.9M</td>
<td>23</td>
<td>2.1K</td>
</tr>
<tr>
<td>ARM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$13.45</td>
<td>$13.0</td>
<td>$13.0</td>
<td>$135.00</td>
<td>$1.3M</td>
<td>576</td>
<td>1.0K</td>
</tr>
<tr>
<td>ARM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/17/27</td>
<td>$44.5</td>
<td>$44.35</td>
<td>$44.35</td>
<td>$125.00</td>
<td>$443.5K</td>
<td>23</td>
<td>2.3K</td>
</tr>
<tr>
<td>ARM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/17/27</td>
<td>$48.75</td>
<td>$47.3</td>
<td>$48.75</td>
<td>$115.00</td>
<td>$243.7K</td>
<td>11.8K</td>
<td>50</td>
</tr>
<tr>
<td>ARM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$13.7</td>
<td>$13.4</td>
<td>$13.7</td>
<td>$115.00</td>
<td>$179.4K</td>
<td>1.6K</td>
<td>510</td>
</tr>
</tbody>
</table>
</p>
<h3>About ARM Holdings</h3>
<p>Arm Holdings is the intellectual property owner and developer of the ARM architecture, which is used in 99% of the world's smartphone CPU cores, and it also has high market share in other battery-powered devices like wearables, tablets, or sensors. Arm licenses its architecture for a fee, offering different types of licenses depending on the flexibility the customer needs. Customers like Apple or Qualcomm buy architectural licenses, which allow them to modify the architecture and add or delete instructions to tailor the chips to their specific needs. Other clients directly buy off-the-shelf designs from Arm. Both off-the-shelf and architectural customers pay a royalty fee per chip shipped.</p>
<p>Having examined the options trading patterns of ARM Holdings, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of ARM Holdings</h3>
<ul>
<li>With a trading volume of 1,128,375, the price of ARM is down by -1.74%, reaching $121.13.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 2 days from now.</li>
</ul>
<h3>What The Experts Say On ARM Holdings</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $146.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on ARM Holdings with a target price of $165.<br />
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on ARM Holdings with a target price of $144.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on ARM Holdings, which currently sits at a price target of $150.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for ARM Holdings, targeting a price of $125. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for ARM Holdings, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Decoding ARM Holdings's Options Activity: What's the Big Picture?

<p>Deep-pocketed investors have adopted a bullish approach towards Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BAC usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Bank of America. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 37% bearish. Among these notable options, 2 are puts, totaling $107,722, and 6 are calls, amounting to $398,615.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $28.0 to $50.0 for Bank of America during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Bank of America's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Bank of America's substantial trades, within a strike price spectrum from $28.0 to $50.0 over the preceding 30 days.</p>
<h3>Bank of America 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457331_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$13.3</td>
<td>$13.2</td>
<td>$13.2</td>
<td>$28.00</td>
<td>$132.0K</td>
<td>5.1K</td>
<td>0</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/18/26</td>
<td>$2.79</td>
<td>$2.75</td>
<td>$2.75</td>
<td>$47.00</td>
<td>$82.5K</td>
<td>10.8K</td>
<td>450</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/23/25</td>
<td>$0.75</td>
<td>$0.73</td>
<td>$0.73</td>
<td>$40.00</td>
<td>$81.2K</td>
<td>1.2K</td>
<td>1.1K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$1.88</td>
<td>$1.85</td>
<td>$1.85</td>
<td>$50.00</td>
<td>$55.5K</td>
<td>4.9K</td>
<td>301</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.4</td>
<td>$6.4</td>
<td>$6.4</td>
<td>$35.00</td>
<td>$48.0K</td>
<td>21.5K</td>
<td>81</td>
</tr>
</tbody>
</table>
</p>
<h3>About Bank of America</h3>
<p>Bank of America is one of the largest financial institutions in the United States, with more than $3.2 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.</p>
<h3>Where Is Bank of America Standing Right Now?</h3>
<ul>
<li>With a trading volume of 6,995,087, the price of BAC is up by 0.67%, reaching $41.34.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 72 days from now.</li>
</ul>
<h3>Expert Opinions on Bank of America</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $48.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from UBS persists with their Buy rating on Bank of America, maintaining a target price of $50.<br />
&#x2A; An analyst from RBC Capital has decided to maintain their Outperform rating on Bank of America, which currently sits at a price target of $45.<br />
&#x2A; An analyst from Argus Research persists with their Buy rating on Bank of America, maintaining a target price of $47.<br />
&#x2A; An analyst from Morgan Stanley upgraded its action to Overweight with a price target of $47.<br />
&#x2A; An analyst from Oppenheimer persists with their Outperform rating on Bank of America, maintaining a target price of $51. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Bank of America, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Looking At Bank of America's Recent Unusual Options Activity

<p>Mosaic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-06. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Mosaic will report an <strong>earnings per share</strong> (EPS) of $0.45.</p>
<p>Mosaic bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Past Earnings Performance</h3>
<p>The company's EPS missed by $0.12 in the last quarter, leading to a 4.66% drop in the share price on the following day.</p>
<p>Here's a look at Mosaic's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.57</td>
<td>0.54</td>
<td>0.66</td>
<td>0.66</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.45</td>
<td>0.34</td>
<td>0.54</td>
<td>0.65</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-5.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457330_0.png" alt="eps graph" /></p>
<h3>Tracking Mosaic's Stock Performance</h3>
<p>Shares of Mosaic were trading at $30.51 as of May 02. Over the last 52-week period, shares are up 3.03%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Views on Mosaic</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Mosaic.</p>
<p>The consensus rating for Mosaic is Neutral, derived from 13 analyst ratings. An average one-year price target of $29.69 implies a potential 2.69% downside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of CF Industries Holdings, FMC and Intrepid Potash, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for CF Industries Holdings, with an average 1-year price target of $85.3, suggesting a potential 179.58% upside.</li>
<li>Analysts currently favor an Neutral trajectory for FMC, with an average 1-year price target of $47.54, suggesting a potential 55.82% upside.</li>
<li>Analysts currently favor an Sell trajectory for Intrepid Potash, with an average 1-year price target of $19.5, suggesting a potential 36.09% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for CF Industries Holdings, FMC and Intrepid Potash, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mosaic</td>
<td>Neutral</td>
<td>-10.59%</td>
<td>$301.90M</td>
<td>1.45%</td>
</tr>
<tr>
<td>CF Industries Holdings</td>
<td>Neutral</td>
<td>-2.99%</td>
<td>$524M</td>
<td>6.44%</td>
</tr>
<tr>
<td>FMC</td>
<td>Neutral</td>
<td>-13.79%</td>
<td>$316.70M</td>
<td>-0.35%</td>
</tr>
<tr>
<td>Intrepid Potash</td>
<td>Sell</td>
<td>-1.52%</td>
<td>$7.29M</td>
<td>-35.85%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Mosaic ranks in the middle for revenue growth among its peers. It is at the bottom for gross profit and return on equity.</p>
<h3>Delving into Mosaic's Background</h3>
<p>Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.</p>
<h3>Mosaic's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Mosaic's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately <strong>-10.59%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Mosaic's net margin excels beyond industry benchmarks, reaching <strong>6.0%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>1.45%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>0.73%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Mosaic's debt-to-equity ratio is below the industry average. With a ratio of <b>0.39</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/MOS/earnings"><strong>To track all earnings releases for Mosaic visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Mosaic

<p><a href="https://www.quiverquant.com/congresstrading/politician/April%20McClain%20Delaney-M001232" title="https://www.quiverquant.com/congresstrading/politician/April%20McClain%20Delaney-M001232">https://www.quiverquant.com/congresstrading/politician/April%20McClain%20Delaney-M001232</a></p>


Trading Ideas

TECH

Watching Bio-Techne; Shares See A Pop In Volume, Traders Circulate Quiver Quantitative Update Showing Representative April McClain Delaney Filed A New Position Between $1,001-$15,000 In The Company

<p>Montrose Environmental Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEG#NYSE">MEG</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-02-26. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Montrose Environmental Gr will report an <strong>earnings per share</strong> (EPS) of $0.31.</p>
<p>Investors in Montrose Environmental Gr are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the last quarter, the company reported an EPS beat by $0.06, leading to a 2.95% drop in the share price on the subsequent day.</p>
<p>Here's a look at Montrose Environmental Gr's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.31</td>
<td>0.35</td>
<td>-0.22</td>
<td>-0.45</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.29</td>
<td>0.41</td>
<td>0.20</td>
<td>0.16</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>33.0%</td>
<td>-3.0%</td>
<td>0.0%</td>
<td>-9.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457322_0.png" alt="eps graph" /></p>
<h3>Montrose Environmental Gr Share Price Analysis</h3>
<p>Shares of Montrose Environmental Gr were trading at $15.47 as of May 02. Over the last 52-week period, shares are down 67.67%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MEG/earnings"><strong>To track all earnings releases for Montrose Environmental Gr visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights into Montrose Environmental Gr's Upcoming Earnings

<p>Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Constellation Energy to report an <strong>earnings per share</strong> (EPS) of $2.17.</p>
<p>Anticipation surrounds Constellation Energy's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company beat EPS by $0.58, leading to a 1.21% drop in the share price the following trading session.</p>
<p>Here's a look at Constellation Energy's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.86</td>
<td>2.64</td>
<td>1.71</td>
<td>1.49</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.44</td>
<td>2.74</td>
<td>1.68</td>
<td>1.82</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>3.0%</td>
<td>-1.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746457303_0.png" alt="eps graph" /></p>
<h3>Constellation Energy Share Price Analysis</h3>
<p>Shares of Constellation Energy were trading at $247.26 as of May 02. Over the last 52-week period, shares are up 22.34%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Insights Shared by Analysts on Constellation Energy</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Constellation Energy.</p>
<p>The consensus rating for Constellation Energy is Buy, based on 5 analyst ratings. With an average one-year price target of $276.6, there's a potential 11.87% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Duke Energy, American Electric Power and Southern, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Duke Energy, with an average 1-year price target of $127.12, suggesting a potential 48.59% downside.</li>
<li>Analysts currently favor an Outperform trajectory for American Electric Power, with an average 1-year price target of $111.8, suggesting a potential 54.78% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Southern, with an average 1-year price target of $94.0, suggesting a potential 61.98% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Duke Energy, American Electric Power and Southern, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Constellation Energy</td>
<td>Buy</td>
<td>-7.14%</td>
<td>$1.30B</td>
<td>6.62%</td>
</tr>
<tr>
<td>Duke Energy</td>
<td>Neutral</td>
<td>2.05%</td>
<td>$3.90B</td>
<td>2.45%</td>
</tr>
<tr>
<td>American Electric Power</td>
<td>Outperform</td>
<td>2.60%</td>
<td>$3.05B</td>
<td>2.48%</td>
</tr>
<tr>
<td>Southern</td>
<td>Neutral</td>
<td>16.99%</td>
<td>$3.74B</td>
<td>3.98%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Constellation Energy ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.</p>
<h3>Unveiling the Story Behind Constellation Energy</h3>
<p>Constellation Energy Corp producer of carbon-free energy and a supplier of energy products and services. The company offers generating capacity that includes nuclear, wind, solar, natural gas, and hydroelectric assets. It sells electricity, natural gas, and other energy-related products and sustainable solutions to various types of customers, including distribution utilities, municipalities, cooperatives, and commercial, industrial, public sector, and residential customers in markets across multiple geographic regions. Its operating segments and reporting units are Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions.</p>
<h3>A Deep Dive into Constellation Energy's Financials</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Constellation Energy's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately <strong>-7.14%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Utilities sector.</p>
<p><strong>Net Margin:</strong> Constellation Energy's net margin is impressive, surpassing industry averages. With a net margin of <strong>15.83%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Constellation Energy's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>6.62%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Constellation Energy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.63%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Constellation Energy's debt-to-equity ratio is below the industry average at <strong>0.64</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/CEG/earnings"><strong>To track all earnings releases for Constellation Energy visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Comments

Ameritrust

Ameritrust (ATCC) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO